Chief executive

Christopher Boerner

Chief Executive Officer · Bristol Myers Squibb Co

1 disclosed trade · 20 Feb 2025 to 20 Feb 2025 · latest filed 21 Feb 2025

Chief executive of Bristol Myers Squibb Co (BMY), tracked from the executive's own SEC Form 4 disclosures.

Net buying by company

Estimated net buying by company: disclosed buys minus sells, trades from 20 Feb 2025 to 20 Feb 2025. Source: SEC Form 4 filings, filed to 21 Feb 2025.
CompanyShare of net buyingEst. net
Common Stock, $0.10 par value (BMY)100.0%$110K

Recent disclosed trades

1 most recent of 1 trades. Amounts are shares times the reported price. Source: SEC Form 4 filings, filed to 21 Feb 2025.
CompanyTrade dateActionAmountFiled
Common Stock, $0.10 par value (BMY)2025-02-20Buy$110,0962025-02-21

Source: SEC Form 4 filings, trades from 20 Feb 2025 to 20 Feb 2025, latest filed 21 Feb 2025. Executives report their own trades on Form 4 within two business days.

Open the interactive profile: all trades, compare with others